krds peptide has been researched along with thromboxane a2 in 1 studies
| Studies (krds peptide) | Trials (krds peptide) | Recent Studies (post-2010) (krds peptide) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caen, JP; Grelac, F; Lévy-Toledano, S; Maclouf, J | 1 |
1 other study(ies) available for krds peptide and thromboxane a2
| Article | Year |
|---|---|
KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amino Acid Sequence; Animals; Arachidonic Acid; Blood Proteins; Cattle; Depression, Chemical; Humans; Lactoferrin; Molecular Sequence Data; Peptide Fragments; Phosphoproteins; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandin-Endoperoxide Synthases; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Signal Transduction; Thrombin; Thromboxane A2 | 1995 |